A Machine Learning Framework Enables Supervised Treatment Response Prediction from Tumor Transcriptomics across Cancer Types.
Robustness analysis revealed that predictive performance plateaued for some therapies with increasing training cohorts but continued to improve for others, suggesting inherent limits of supervised brute-force learning for certain treatments, but additional data and deeper mechanistic modeling may further enhance transc...